1389264-13-4 Usage
Uses
Used in Chemical Research:
2-Aza-tricyclo[3.3.1.13,7]decane-5-carboxylic acid Methyl ester hydrochloride is used as a research compound for its unique tricyclic structure and functional groups, which may be of interest in the development of new chemical entities or for studying reaction mechanisms.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-Aza-tricyclo[3.3.1.13,7]decane-5-carboxylic acid Methyl ester hydrochloride is used as a potential lead compound for the design and synthesis of new drugs. Its complex structure and functional groups may offer opportunities for the development of novel therapeutic agents with unique pharmacological properties.
Used in Drug Delivery Systems:
2-Aza-tricyclo[3.3.1.13,7]decane-5-carboxylic acid Methyl ester hydrochloride may also be utilized in the development of drug delivery systems, where its tricyclic structure and functional groups could be exploited to enhance the solubility, stability, or bioavailability of therapeutic agents. This could lead to improved drug formulations and more effective treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1389264-13-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,9,2,6 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1389264-13:
(9*1)+(8*3)+(7*8)+(6*9)+(5*2)+(4*6)+(3*4)+(2*1)+(1*3)=194
194 % 10 = 4
So 1389264-13-4 is a valid CAS Registry Number.
1389264-13-4Relevant academic research and scientific papers
DERIVATIVES OF AZA ADAMANTANE AND USES THEREOF
-
, (2013/08/15)
The present invention relates to certain amide derivatives that have the ability to inhibit 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
